QHC Insider Trading Activity and SEC Form 4 Filings
QHC insider trading summary
No open-market insider purchases or sales of Quorum Health Corp (QHC) have been reported on SEC Form 4 in the past 12 months.
Latest QHC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 13, 2017 | Shaheed Koury | SVP and Chief Medical Officer | Buy | $47K (10,000 @ $4.69) |
| May 25, 2017 | Shaheed Koury | SVP and Chief Medical Officer | Buy | $30K (8,500 @ $3.56) |
| May 18, 2017 | Shaheed Koury | SVP and Chief Medical Officer | Buy | $27K (10,000 @ $2.72) |
| May 18, 2017 | Ray Harold McCard Jr | SVP and General Counsel | Buy | $11K (4,000 @ $2.67) |
| May 18, 2017 | Thomas Daniel Miller | President and CEO | Buy | $527K (185,000 @ $2.85) |
| Aug 15, 2016 | Shaheed Koury | SVP and Chief Medical Officer | Buy | $59K (10,000 @ $5.86) |
| Aug 15, 2016 | James Matthew Hayes | SVP - Operations | Buy | $51K (8,800 @ $5.83) |
| Aug 15, 2016 | Michael J Culotta | EVP and CFO | Buy | $478K (80,000 @ $5.98) |
| Aug 15, 2016 | William S Hussey | Director | Buy | $29K (5,000 @ $5.83) |
| Aug 15, 2016 | Thomas Daniel Miller | President and CEO | Buy | $282K (48,200 @ $5.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.